Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


FDA consolidation project

This article was originally published in The Tan Sheet

Executive Summary

House and Senate conferees approve $35 mil. for construction of a 100,000 sq. ft. CDER laboratory facility at the former White Oak Naval Surface Warfare Center in Montgomery County, Md. The funding was approved as part of the FY 2000 Treasury, Postal Service & General Government Appropriations bill passed by conference committee Sept. 9. Funding for the project matches that of the original Senate bill, but is less than the $56 mil. included in the President's budget proposal (1"The Tan Sheet" Feb. 8, p. 16). The House markup of appropriations for the Federal Building Fund did not include any funding for the White Oak consolidation

You may also be interested in...

FDA White Oak Consolidation Funding Supported In FY 2000 Budget

The Clinton Administration's budget for FY 2000, released Feb. 1, sets aside roughly $56 mil. in federal funds for the design and construction of a consolidated FDA research campus on a 130-acre site at the former White Oak Naval Research Base in Montgomery County, Md.

Supplement GMP Warning Letters Make Modest Debut In 2010

Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC

People In Brief

Perrigo promotes in pricing, planning





Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts